Dynacirc and Alprazolam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dynacirc (isradipine) and Alprazolam (alprazolam). Common drug interactions include erythema among females and nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Dynacirc and Alprazolam. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Dynacirc?

Dynacirc has active ingredients of isradipine. eHealthMe is studying from 975 Dynacirc users. Check the latest studies of Dynacirc.

What is Alprazolam?

Alprazolam has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 134,864 Alprazolam users. Check the latest studies of Alprazolam.

On Aug, 02, 2026

15 people who take Dynacirc and Alprazolam together, and have interactions are studied.

Dynacirc and Alprazolam drug interactions.

What are the common drug interactions of Dynacirc and Alprazolam, by gender? *:

female:

Erythema (redness of the skin)
Muscle swelling
Neuralgia (pain in one or more nerves)
Oedema peripheral (superficial swelling)
Cataract (clouding of the lens inside the eye)
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Nausea (feeling of having an urge to vomit)
Pain in extremity
Vision blurred
Alopecia (absence of hair from areas of the body)

male:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Emotional distress
General physical health deterioration (weak health status)
Injury
Mobility decreased (ability to move is reduced)
Pain
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Skin tightness
Discomfort

What are the common drug interactions of Dynacirc and Alprazolam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Alopecia (absence of hair from areas of the body)
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Drug ineffective
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Headache (pain in head)
Malaise (a feeling of general discomfort or uneasiness)
Myalgia (muscle pain)
Myasthenic syndrome (a group of conditions characterized by muscle weakness (myasthenia) that worsens with physical exertion)
Nausea (feeling of having an urge to vomit)

50-59:

n/a

60+:

Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
Chronic kidney disease
Dyspepsia (indigestion)
Emotional distress
General physical health deterioration (weak health status)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Hypertension (high blood pressure)
Hypoacusis (loss of hearing)
Injury
Insomnia (sleeplessness)

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 40.00%
Oedema (fluid collection in tissue): 5 people, 33.33%
Thinking Abnormal: 1 person, 6.67%
Quit Smoking: 1 person, 6.67%
Pain: 1 person, 6.67%
Multiple Myeloma (cancer of the plasma cells): 1 person, 6.67%
Inflammation: 1 person, 6.67%
Indigestion: 1 person, 6.67%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Dynacirc and Alprazolam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously